TOP NEWS

Trovagene Raises $15M In PIPE

San Diego-based molecular diagnostics developer Trovagene announced this morning that it has raised $15M in a registered direct offering of its common stock. The publicly held company, which trades on the NASDAQ as TROV, said the shares were sold directly to an un-named institutional investor. The company said the new funding will go towards research and development activities and for working capital and other general corporate purposes.


LATEST HEADLINES

More Headlines

BROWSE ISSUES